This article discusses the use of stereotactic radiosurgery (SRS) as a treatment option for intracranial solitary fibrous tumors (SFTs). SFTs are rare tumors that are difficult to completely remove through surgery and have high recurrence rates. SRS, which delivers targeted radiation to the tumor, has shown promise in improving local tumor control without significant adverse effects. The study found that increasing the margin dose of SRS may lead to better tumor control. However, more research is needed to develop an optimal dosing strategy for SRS in the treatment of SFTs. [Extracted from the article]